These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27806034)

  • 1. Antimicrobial resistance in New Zealand: the evidence and a call for action.
    Pullon HW; Gommans J; Thomas MG; Metcalf S; Grainger R; Wild H
    N Z Med J; 2016 Oct; 129(1444):103-110. PubMed ID: 27806034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing landscape of antimicrobial resistance in New Zealand.
    Williamson DA; Heffernan H
    N Z Med J; 2014 Sep; 127(1403):41-54. PubMed ID: 25290498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Success stories of implementation of antimicrobial stewardship: a narrative review.
    Huttner B; Harbarth S; Nathwani D;
    Clin Microbiol Infect; 2014 Oct; 20(10):954-62. PubMed ID: 25294340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of antimicrobial resistant disease threats in Canada.
    Garner MJ; Carson C; Lingohr EJ; Fazil A; Edge VL; Trumble Waddell J
    PLoS One; 2015; 10(4):e0125155. PubMed ID: 25905797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moving forward in tackling antimicrobial resistance: WHO actions.
    Lusti-Narasimhan M; Pessoa-Silva CL; Temmerman M
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv57-9. PubMed ID: 24202206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A collaborative initiative for the containment of antimicrobial resistance in Mexico.
    Zaidi MB; Dreser A; Figueroa IM
    Zoonoses Public Health; 2015 Apr; 62 Suppl 1():52-7. PubMed ID: 25418055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological factors influencing the emergence of antimicrobial resistance.
    Cohen ML
    Ciba Found Symp; 1997; 207():223-31; discussion 231-7. PubMed ID: 9189644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail.
    Goff DA; Kullar R; Goldstein EJC; Gilchrist M; Nathwani D; Cheng AC; Cairns KA; Escandón-Vargas K; Villegas MV; Brink A; van den Bergh D; Mendelson M
    Lancet Infect Dis; 2017 Feb; 17(2):e56-e63. PubMed ID: 27866945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding beyond zoonoses: the benefits of a national One Health coordination mechanism to address antimicrobial resistance and other shared health threats at the human-animal-environment interface in Kenya.
    Kimani T; Kiambi S; Eckford S; Njuguna J; Makonnen Y; Rugalema G; Morzaria SP; Lubroth J; Fasina FO
    Rev Sci Tech; 2019 May; 38(1):155-171. PubMed ID: 31564733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring antimicrobial resistance for public health action.
    Tapsall JW
    Commun Dis Intell Q Rep; 2003; 27 Suppl():S70-4. PubMed ID: 12807278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing US-Japan cooperation to combat antimicrobial resistance.
    Gerbin CS
    Biosecur Bioterror; 2014; 12(6):337-45. PubMed ID: 25470465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combating antimicrobial resistance demands nation-wide action and global governance.
    Metcalfe S; Baker MG; Freeman J; Wilson N; Murray P
    N Z Med J; 2016 Oct; 129(1444):8-14. PubMed ID: 27806025
    [No Abstract]   [Full Text] [Related]  

  • 13. A governance framework for development and assessment of national action plans on antimicrobial resistance.
    Anderson M; Schulze K; Cassini A; Plachouras D; Mossialos E
    Lancet Infect Dis; 2019 Nov; 19(11):e371-e384. PubMed ID: 31588040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct detection of markers associated with Neisseria gonorrhoeae antimicrobial resistance in New Zealand using residual DNA from the Cobas 4800 CT/NG NAAT assay.
    Nicol M; Whiley D; Nulsen M; Bromhead C
    Sex Transm Infect; 2015 Mar; 91(2):91-3. PubMed ID: 25365962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-acquired methicillin-resistant Staphylococcus aureus--a review of literature.
    Okesola AO
    Afr J Med Med Sci; 2011 Jun; 40(2):97-107. PubMed ID: 22195376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global analysis of strategies to tackle antimicrobial resistance.
    Adeniji F
    Int J Pharm Pract; 2018 Feb; 26(1):85-89. PubMed ID: 28544416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Resistance, Food Safety, and One Health: The Need for Convergence.
    Lammie SL; Hughes JM
    Annu Rev Food Sci Technol; 2016; 7():287-312. PubMed ID: 26772408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of measures to assess prevention and control of AMR in hospitals.
    Flanagan M; Ramanujam R; Sutherland J; Vaughn T; Diekema D; Doebbeling BN
    Med Care; 2007 Jun; 45(6):537-44. PubMed ID: 17515781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.
    Chua K; Laurent F; Coombs G; Grayson ML; Howden BP
    Clin Infect Dis; 2011 Jan; 52(1):99-114. PubMed ID: 21148528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clear and present danger of carbapenemase-producing Enterobacteriaceae (CPE) in New Zealand: time for a national response plan.
    Blakiston M; Heffernan H; Roberts S; Freeman J
    N Z Med J; 2017 Apr; 130(1454):72-79. PubMed ID: 28449019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.